Jyrki Lilleberg

835 total citations
17 papers, 654 citations indexed

About

Jyrki Lilleberg is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Emergency Medicine. According to data from OpenAlex, Jyrki Lilleberg has authored 17 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Emergency Medicine. Recurrent topics in Jyrki Lilleberg's work include Heart Failure Treatment and Management (11 papers), Cardiac pacing and defibrillation studies (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Jyrki Lilleberg is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Cardiac pacing and defibrillation studies (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Jyrki Lilleberg collaborates with scholars based in Finland, United States and United Kingdom. Jyrki Lilleberg's co-authors include Markku S. Nieminen, S. Sundberg, Lasse Lehtonen, Lauri Toivonen, Markku Kupari, Mikaela A. Laine, Matti Kivikko, Pasi Pohjanjousi, Stig Sundberg and Juha Akkila and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jyrki Lilleberg

16 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jyrki Lilleberg Finland 10 585 141 131 90 70 17 654
V.S. Moiseyev Russia 6 550 0.9× 171 1.2× 112 0.9× 105 1.2× 95 1.4× 7 620
Michael R. Bristow United States 8 529 0.9× 84 0.6× 119 0.9× 25 0.3× 68 1.0× 9 638
Howard Rutman United States 13 500 0.9× 55 0.4× 72 0.5× 37 0.4× 46 0.7× 19 596
Srdjan D. Nikolic United States 9 508 0.9× 100 0.7× 161 1.2× 37 0.4× 105 1.5× 12 636
Matthias R. Schulze Germany 6 331 0.6× 86 0.6× 84 0.6× 60 0.7× 178 2.5× 10 423
Ali İhsan Parlar Türkiye 12 215 0.4× 79 0.6× 185 1.4× 39 0.4× 77 1.1× 51 374
Peter R. Lichtenthal United States 12 312 0.5× 85 0.6× 200 1.5× 118 1.3× 73 1.0× 34 579
Melike Bayram United States 6 259 0.4× 61 0.4× 175 1.3× 32 0.4× 149 2.1× 8 500
Joseph Walden United States 3 499 0.9× 67 0.5× 138 1.1× 33 0.4× 31 0.4× 9 575
Salih Fehmi Katırcıoğlu Türkiye 12 251 0.4× 86 0.6× 223 1.7× 62 0.7× 120 1.7× 66 484

Countries citing papers authored by Jyrki Lilleberg

Since Specialization
Citations

This map shows the geographic impact of Jyrki Lilleberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyrki Lilleberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyrki Lilleberg more than expected).

Fields of papers citing papers by Jyrki Lilleberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyrki Lilleberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyrki Lilleberg. The network helps show where Jyrki Lilleberg may publish in the future.

Co-authorship network of co-authors of Jyrki Lilleberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jyrki Lilleberg. A scholar is included among the top collaborators of Jyrki Lilleberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyrki Lilleberg. Jyrki Lilleberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Eskola, Markku, et al.. (2018). Outcome of all-comers with STEMI based on the grade of ischemia in the presenting ECG. Journal of Electrocardiology. 51(4). 598–606. 2 indexed citations
2.
Nikus, Kjell, et al.. (2018). Comparison of the prognostic role of Q waves and inverted T waves in the presenting ECG of STEMI patients. Annals of Noninvasive Electrocardiology. 24(1). e12585–e12585. 6 indexed citations
3.
Laine, Mika, et al.. (2014). Trends in treatment delays for patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. BMC Cardiovascular Disorders. 14(1). 115–115. 11 indexed citations
4.
Lilleberg, Jyrki, Ilkka Tierala, Mikko Syvänne, et al.. (2013). Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: The Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI). European Heart Journal Acute Cardiovascular Care. 2(4). 371–378. 8 indexed citations
5.
Lilleberg, Jyrki, et al.. (2006). Duration of the Haemodynamic Action of a 24-h Infusion of Levosimendan in Patients with Congestive Heart Failure. European Journal of Heart Failure. 9(1). 75–82. 99 indexed citations
6.
Lilleberg, Jyrki, et al.. (2004). The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scandinavian Cardiovascular Journal. 38(2). 80–84. 49 indexed citations
8.
Lilleberg, Jyrki & L. Toivonen. (2002). Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure. Critical Care. 6(Suppl 1). P139–P139. 1 indexed citations
11.
Lilleberg, Jyrki, S. Sundberg, & Markku S. Nieminen. (1995). Dose-Range Study of a New Calcium Sensitizer, Levosimendan, in Patients with Left Ventricular Dysfunction. Journal of Cardiovascular Pharmacology. 26. 63–69. 54 indexed citations
12.
Sundberg, Stig, Jyrki Lilleberg, Markku S. Nieminen, & Lasse Lehtonen. (1995). Hemodynamic and neurohumoral effects of levosimedan, a new calcium sensitizer, at rest and during exercise in healthy men. The American Journal of Cardiology. 75(15). 1061–1066. 48 indexed citations
13.
Lilleberg, Jyrki, S. Sundberg, & Markku S. Nieminen. (1995). Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction.. PubMed. 26 Suppl 1. S63–9. 58 indexed citations
14.
Lilleberg, Jyrki, S. Sundberg, & Markku S. Nieminen. (1995). Dose-Range Study of a New Calcium Sensitizer, Levosimendan, in Patients with Left Ventricular Dysfunction. Journal of Cardiovascular Pharmacology. 26. 63–69. 3 indexed citations
15.
Lilleberg, Jyrki, et al.. (1994). Hemodynamic effects of the novel cardiotonic drug simendan: Echocardiographic assessment in healthy volunteers. Cardiovascular Drugs and Therapy. 8(2). 263–269. 7 indexed citations
16.
Lilleberg, Jyrki, et al.. (1994). Haemodynamic dose-efficacy of levosimendan in healthy volunteers. European Journal of Clinical Pharmacology. 47(3). 267–274. 49 indexed citations
17.
Lilleberg, Jyrki, et al.. (1994). Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers. Clinical Pharmacology & Therapeutics. 56(5). 554–563. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026